Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 18:40:101324.
doi: 10.1016/j.conctc.2024.101324. eCollection 2024 Aug.

Effect of trehalose on mortality and disease severity in ICU-admitted patients: Protocol for a triple-blind, randomized, placebo-controlled clinical trial

Mehrdad Sahranavard  1 , Hesamoddin Hosseinjani  2 , Maryam Emadzadeh  3 , Tannaz Jamialahmadi  4   5 , Amirhossein Sahebkar  1   6
Affiliations

Effect of trehalose on mortality and disease severity in ICU-admitted patients: Protocol for a triple-blind, randomized, placebo-controlled clinical trial

Mehrdad Sahranavard et al. Contemp Clin Trials Commun. .

Abstract

Background: Improvement in organ failure in intensive care unit (ICU) patients is accompanied by lower mortality rate. A disaccharide, trehalose is a candidate to improve organ failure and survival by autophagy induction and enhancing oxidative stress defense. The aim of this study is to assess the effectiveness of trehalose in improving clinical outcome and reducing mortality in ICU patients.

Methods: a triple-blind, randomized, placebo-controlled, two arm, parallel-group, superiority clinical trial will enroll 200 ICU-admitted patients at Imam Reza hospital, Mashhad, Iran. The patients will be randomly allocated to receive either a 100 ml solution of 15 % trehalose or normal saline intravenously. Primary outcomes include ICU mortality and 60-day mortality, while secondary outcomes focus on blood parameters on day 5 and length of hospital/ICU stay.

Conclusion: Trehalose has demonstrated beneficial effects in diverse patients; however, no study has evaluated its effect in all ICU-admitted patients. Consequently, this study provides an opportunity to investigate whether trehalose's anti-inflammatory effects, mediated by inducing autophagy and enhancing oxidative stress defense, can play a role in reducing mortality and improving clinical outcomes in the critically ill patients. If successful, trehalose could offer a potential therapeutic approach in the ICU setting.

Keywords: Clinical trial; Critical illness; Intensive care units; Mortality; Survival; Treatment outcome; Trehalose.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
- Flow diagram of the clinical trial protocol.
See this image and copyright information in PMC

References

    1. Vincent J.-L., Marshall J.C., Ñamendys-Silva S.A., François B., Martin-Loeches I., Lipman J., et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir. Med. 2014;2(5):380–386. - PubMed
    1. Endeshaw A.S., Tarekegn F., Bayu H.T., Ayalew S.B., Gete B.C. The magnitude of mortality and its determinants in Ethiopian adult intensive care units: a systematic review and meta-analysis. Ann. Med. Surg. 2022 - PMC - PubMed
    1. Didriksson I., Leffler M., Spångfors M., Lindberg S., Reepalu A., Nilsson A., et al. Intensive care unit burden is associated with increased mortality in critically ill COVID‐19 patients. Acta Anaesthesiol. Scand. 2023;67(3):329–338. - PMC - PubMed
    1. Vincent J.-L., editor. Seminars in Respiratory and Critical Care Medicine. © Thieme Medical Publishers; 2011. Organ failure in the intensive care unit. - PubMed
    1. Sakr Y., Lobo S.M., Moreno R.P., Gerlach H., Ranieri V.M., Michalopoulos A., et al. Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit. Care. 2012;16(6):1–9. - PMC - PubMed

LinkOut - more resources